Search Tag: Roche

Roche: Changes in the Board of Directors

2021 03 Dec

Roche announced that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting (AGM) scheduled for 15 March 2022. Mr Paul Bulcke, who has been serving on the Board of Directors since 2011, has decided not to stand for re-election at the AGM in 2022, following almost eleven years... Read more

Digital Solutions Are the Now and the Future of Diabetes Management

2021 20 Oct

Diabetes is a chronic disease that requires daily management including lifestyle and behavioural modifications, compliance with medications, blood glucose control and close patient monitoring, all of which can be efficiently supported by digital solutions. Diabetes is a global health crisis. Recent estimates suggest the incidence of diabetes... Read more

Christopher Bird Announced as New Chief Medical Officer of BioPorto

2019 01 Jul

The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer. Bird joins BioPorto from his role at Roche Diagnostics as Head of Medical and Scientific Affairs in North America. After over 10 years with this medical and scientific affairs organisation, Christopher will... Read more

Social Media in the Pharmaceutical Industry 2016

2016 20 Jan

As the debate and uncertainties regarding Pharma and Social Media continue to heighten, SMi are once again, kicking off the brand new year with this highly engaging and innovative event. Social media, being the prime location for global conversations plays a central role in pharma covigilance and digital marketing, as well as understanding trends,... Read more

Roche Launches Improved POC Troponin Test to Diagnose Heart Attack Patients at High Mortality Risk

2015 29 Jun

Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced that its improved CARDIAC point-of-care Troponin T test for the cobas h 232 system is now available for countries accepting the CE Mark*. The test allows healthcare professionals to identify patients with a suspected acute myocardial infarction (AMI), termed also heart attack, with greater accuracy at... Read more

Pertuzumab: Metastatic Breast Cancer Breakthrough Drug

2014 06 Oct

At the most recent European Society of Oncology meeting in Madrid, the results for the CLEOPATRA breast cancer study on Roche's Perjeta (pertuzumab) were presented. The results were declared to be extraordinary and unprecedented. “Many of us work our whole career to have this kind of data,” said Sandra Swain, medical director of the Washington... Read more

Arab Health 2014: Roche Premieres Region’s First Blood Safety Solution Portfolio

2014 28 Jan

Roche Diagnostics Middle East launches the region’s first comprehensive Roche Blood Safety Solution (RBSS) portfolio at Arab Health • The only comprehensive RBSS portfolio of serology screening solutions and nucleic acid testing (NAT) available in the Middle East from a single source • RBSS safeguards patients through industry-leading assays... Read more

Roche Launches New ProGRP Test for More Precise Diagnosis in Lung Cancer

2013 18 Jul

New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu Roche today announced the global launch (except US) of Elecsys ProGRP, a test that distinguishes between the two main types of lung cancer – small cell (SCLC) and non-small cell (NSCLC) lung cancer – and can help diagnose early-stage... Read more